Welcome!

Our research interests lie at the interface of immune-oncology, nucleic acid theranostics, immunotherapy, and functional biomaterials. My current focus is developing therapeutics and vaccines for cancer immunotherapy, infectious disease prevention, and treatment of autoimmune diseases and genetic disorders.

• Engineering of novel circular RNA (circRNA) and lipid nanoparticles for circRNA delivery in cancer immunotherapy, mucosal vaccine, and treatment of autoimmune diseases and genetic disorders;

• ADAR-targeted nucleic acid theranostics and immunomodulators;

• cGAS-STING-targeted immunomodulation for the immunotherapy of cancer and beyond;

• lipid nanoparticles for the delivery of RNA therapeutics and vaccines.